The consultant and founder of Accelerating NeuroVentures talked about the pridopidine arm from the HEALEY ALS Platform trial, which showed significant benefits in speech measures. [WATCH TIME: 5 minutes]
Melanie Leitner, PhD
Advertisement
Consultant and founder of Accelerating NeuroVentures.
Articles by Melanie Leitner, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment
2
FDA Issues Complete Response Letter for Spinocerebellar Ataxia Agent Troriluzole
3
Early-Stage Study to Test CD19 CAR T-Cell Therapy YTB323 in Myasthenia Gravis
4
FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency
5
